Efficacy and Tolerability of Ramelteon in Patients With REM Behavior Disorder and Parkinsonism: A Placebo Controlled, Double Blind, Randomized, Prospective Pilot Study.
Phase of Trial: Phase III
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Ramelteon (Primary)
- Indications Sleep disorders
- Focus Therapeutic Use
- 09 Nov 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 18 Sep 2008 New trial record.